Search...
Wells Fargo Sticks to Its Buy Rating for Milestone Pharmaceuticals (MIST)
I'm PortAI, I can summarize articles.
Wells Fargo analyst Mohit Bansal maintained a Buy rating on Milestone Pharmaceuticals with a $4.00 price target. Bansal, a 4-star analyst with a 9.4% average return, covers the Healthcare sector. H.C. Wainwright also reiterated a Buy rating with a $5.00 price target.
Wells Fargo analyst Mohit Bansal maintained a Buy rating on Milestone Pharmaceuticals today and set a price target of $4.00.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
According to TipRanks, Bansal is a 4-star analyst with an average return of 9.4% and a 57.61% success rate. Bansal covers the Healthcare sector, focusing on stocks such as Gilead Sciences, Regeneron, and AbbVie.
In a report released yesterday, H.C. Wainwright also reiterated a Buy rating on the stock with a $5.00 price target.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments